Verastem (VSTM) Cash from Investing Activities (2011 - 2026)

Verastem's (VSTM) quarterly Cash from Investing Activities came in at -$16.0 million in Q1 2026, down 1090.71% quarter-over-quarter from -$1.3 million in Q4 2025.

Verastem (VSTM) Cash from Investing Activities (2011 - 2026) Analysis & Trends

Verastem's Cash from Investing Activities history runs 16 years deep, the most recent figure standing at -$16.0 million for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities changed N/A year-over-year to -$16.0 million in Q1 2026; TTM through Mar 2026 was -$17.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$9.6 million, down 116.05% from the prior year.
  • Cash from Investing Activities fell to -$16.0 million in Q1 2026 per VSTM's latest filing, from -$1.3 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $31.0 million in Q1 2024 and bottomed at -$70.1 million in Q3 2023.
  • The 5-year median for Cash from Investing Activities is $12.7 million (2022), against an average of $5.4 million.
  • Across the five-year window, Cash from Investing Activities surged 19634.85% in 2022 and slumped 1608.05% in 2023, its largest moves.
  • Year by year, Cash from Investing Activities stood at $13.0 million in 2022, then slipped by 4.52% to $12.4 million in 2023, then soared by 133.14% to $29.0 million in 2024, then tumbled by 104.64% to -$1.3 million in 2025, then tumbled by 1090.71% to -$16.0 million in 2026.
  • Per Business Quant, the three latest VSTM Cash from Investing Activities figures stand at -$16.0 million (Q1 2026), -$1.3 million (Q4 2025), and $29.0 million (Q2 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 67,042.03 Bn 67,041.74 Bn - -
2 Nanobiotix 1,908.00 Bn 1,907.94 Bn - -
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 472.89 Bn 468.10 Bn 1.35 Bn -45.51 Mn
5 Vertex Pharmaceuticals 122.12 Bn 114.87 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 70.04 Bn 61.29 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 62.68 Bn 62.68 Bn - -
8 Argenx Se 55.90 Bn 50.72 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.47 Bn 34.46 Bn 959.66 Mn -25.54 Mn
10 Verastem 614.82 Mn 416.99 Mn 15.90 Mn -16.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -16.02 Mn
Mar 31, 2026 -16.02 Mn
Dec 31, 2025 -1.35 Mn
Dec 31, 2025 -1.35 Mn
Jun 30, 2024 28.99 Mn
Jun 30, 2024 28.99 Mn
Mar 31, 2024 30.98 Mn
Mar 31, 2024 30.98 Mn
Dec 31, 2023 12.44 Mn
Dec 31, 2023 12.44 Mn
Sep 30, 2023 -70.08 Mn
Sep 30, 2023 -70.08 Mn
Jun 30, 2023 14.00 Mn
Jun 30, 2023 14.00 Mn
Mar 31, 2023 -804,000.00
Mar 31, 2023 -804,000.00
Dec 31, 2022 13.03 Mn
Dec 31, 2022 13.03 Mn
Sep 30, 2022 4.65 Mn
Sep 30, 2022 4.65 Mn